Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Immunotec names new board member
Mr Depatie is the president and CEO of Videotron, a position he has held since June 2003. He joined Videotron in December 2001 as principal vice president of
Mr Depatie is the president and CEO of Videotron, a position he has held since June 2003. He joined Videotron in December 2001 as principal vice president of
The three-year agreement covers the US and will more than double the reach and frequency of the current sales effort for Vyvanse by adding over 600 sales representatives
Through this collaboration, Daiichi Sankyo and Lilly will reinforce the World Heart Federation’s efforts addressing the challenges that result from a cardiac event, such as a heart attack
Amicus Therapeutics, a biopharmaceutical company, has received a new US patent, which covers the tartrate salt form of isofagomine, the active ingredient in the company’s investigational drug Plicera,
The company expects that the patent will be officially issued later in 2009, and if issued, the patent’s initial 20-year term would expire in 2024. The company said
Emtricitabine and tenofovir disoproxil fumarate tablets are the generic version of Gilead Sciences’s Truvada tablets. Truvada is a second-line anti-HIV drug in the nucleoside reverse transcriptase inhibitor family
Epiphany Biosciences, a developer of therapeutic products and diagnostic technologies that treat or help prevent the spread of pathogenic viruses, has reported that it plans to file an
This follows a licensing agreement between the two companies authorizing Ranbaxy to promote and market the drug in India. Olvance (olmesartan medoxomil) is an antihypertensive agent that can
The two new leaders will serve the company’s central and northern Illinois market operations. The announcement comes as a result of Humana’s May 2008 acquisition of OSF HealthPlans
The proceeds of the offering will be used for continued development of a suite of new products and to help fund continuing operations. The completion of the private